Tobacco smoking and cytokine levels in human epicardial adipose tissue: Impact of smoking cessation

Atherosclerosis

Volumn 255, Issue , 2016, Pages 37-42

  Mach, Lukas ^a,b   Bedanova, Helena ^a,c   Soucek, Miroslav ^a   Karpisek, Michal ^d   Nemec, Petr ^a,c   Orban, Marek ^a,c,d  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c Centre of Cardiovascular and Transplant Surgery Brno   (Czech Republic)

^d UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Coronary artery disease; Cytokines; Epicardial adipose tissue; Inflammation; Smoking

Indexed keywords

ADIPONECTIN; FATTY ACID BINDING PROTEIN 4; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR; AUTACOID; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICARDIAL FAT; FEMALE; HEART SURGERY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN DETERMINATION; SMOKING; SMOKING CESSATION; SUBCUTANEOUS FAT; TISSUE LEVEL; METABOLISM; PERICARDIUM; PREVENTION AND CONTROL; UPREGULATION;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PERICARDIUM; SMOKING; SMOKING CESSATION; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84992646522     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.10.022     Document Type: Article

References (32)

1. [1] Mazurek, T., Zhang, L., Zalewski, A., Mannion, J.D., Diehl, J.T., Arafat, H., Sarov-Blat, L., O'Brien, S., Keiper, E.A., Johnson, A.G., Martin, J., Goldstein, B.J., Shi, Y., Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108 (2003), 2460–2466.
2. [2] Shimabukuro, M., Hirata, Y., Tabata, M., Dagvasumberel, M., Sato, H., Kurobe, H., Fukuda, D., Soeki, T., Kitagawa, T., Takanashi, S., Sata, M., Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 1077–1084.
3. [3] Baker, A.R., Silva, N.F., Quinn, D.W., Harte, A.L., Pagano, D., Bonser, R.S., Kumar, S., McTernan, P.G., Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc. Diabetol., 5, 2006, 1.
4. [4] Van de Voorde, J., Pauwels, B., Boydens, C., Decaluwé, K., Adipocytokines in relation to cardiovascular disease. Metabolism 62 (2013), 1513–1521.
5. [5] Parisi, V., Rengo, G., Pagano, G., D'Esposito, V., Passaretti, F., Caruso, A., Grimaldi, M.G., Lonobile, T., Baldascino, F., De Bellis, A., Formisano, P., Ferrara, N., Leosco, D., Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis. Int. J. Cardiol. 186 (2015), 167–169.
6. [6] Mazurek, T., Kiliszek, M., Kobylecka, M., Skubisz-Głuchowska, J., Kochman, J., Filipiak, K., Królicki, L., Opolski, G., Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation. Am. J. Cardiol. 113 (2014), 1505–1508.
7. [7] Kourliouros, A., Karastergiou, K., Nowell, J., Gukop, P., Tavakkoli Hosseini, M., Valencia, O., Mohamed Ali, V., Jahangiri, M., Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery. Eur. J. Cardiothorac. Surg. 39 (2011), 228–232.
8. [8] Critchley, J.A., Capewell, S., Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 290 (2003), 86–97.
9. [9] Mons, U., Müezzinler, A., Gellert, C., Schöttker, B., Abnet, C.C., Bobak, M., de Groot, L., Freedman, N.D., Jansen, E., Kee, F., Kromhout, D., Kuulasmaa, K., Laatikainen, T., O'Doherty, M.G., Bueno-de-Mesquita, B., Orfanos, P., Peters, A., van der Schouw, Y.T., Wilsgaard, T., Wolk, A., Trichopoulou, A., Boffetta, P., Brenner, H., Consortium C. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the chances consortium. BMJ, 350, 2015, h1551.
10. [10] Björck, L., Capewell, S., O'Flaherty, M., Lappas, G., Bennett, K., Rosengren, A., Decline in coronary mortality in Sweden between 1986 and 2002: comparing contributions from primary and secondary prevention. PLoS One, 10, 2015, e0124769.
11. [11] Schoenborn, C.A., Adams, P.E., Health behaviors of adults: United States, 2005-2007. Vital Health Stat. 10 (2010), 1–132.
12. [12] Catapano, A.L., Reiner, Z., De Backer, G., Graham, I., Taskinen, M.R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Filardi, P.P., Riccardi, G., Storey, R.F., Wood, D., (ESC) ESoC, (EAS) EAS. ESC/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS). Atherosclerosis 217 (2011), 3–46.
13. [13] Rydén, L., Grant, P.J., Anker, S.D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H.P., Huikuri, H., Marre, M., Marx, N., Mellbin, L., Ostergren, J., Patrono, C., Seferovic, P., Uva, M.S., Taskinen, M.R., Tendera, M., Tuomilehto, J., Valensi, P., Zamorano, J.L., Achenbach, S., Baumgartner, H., Bax, J.J., Bueno, H., Dean, V., Erol, C., Fagard, R., Ferrari, R., Hasdai, D., Hoes, A.W., Kirchhof, P., Knuuti, J., Kolh, P., Lancellotti, P., Linhart, A., Nihoyannopoulos, P., Piepoli, M.F., Ponikowski, P., Sirnes, P.A., Tamargo, J.L., Torbicki, A., Wijns, W., Windecker, S., De Backer, G., Ezquerra, E.A., Avogaro, A., Badimon, L., Baranova, E., Betteridge, J., Ceriello, A., Funck-Brentano, C., Gulba, D.C., Kjekshus, J.K., Lev, E., Mueller, C., Neyses, L., Nilsson, P.M., Perk, J., Reiner, Z., Sattar, N., Schächinger, V., Scheen, A., Schirmer, H., Strömberg, A., Sudzhaeva, S., Viigimaa, M., Vlachopoulos, C., Xuereb, R.G., Members ATF, (CPG) ECfPG, Reviewers D. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European society of cardiology (ESC) and developed in collaboration with the European association for the study of diabetes (EASD). Eur. Heart J. 34 (2013), 3035–3087.
14. [14] Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L., Investigators, I.S., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): case-control study. Lancet 364 (2004), 937–952.
15. [15] Siasos, G., Tsigkou, V., Kokkou, E., Oikonomou, E., Vavuranakis, M., Vlachopoulos, C., Verveniotis, A., Limperi, M., Genimata, V., Papavassiliou, A.G., Stefanadis, C., Tousoulis, D., Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Curr. Med. Chem. 21 (2014), 3936–3948.
16. [16] Eveborn, G.W., Schirmer, H., Lunde, P., Heggelund, G., Hansen, J.B., Rasmussen, K., Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study. Eur. J. Epidemiol. 29 (2014), 567–575.
17. [17] Ferreira-González, I., Pinar-Sopena, J., Ribera, A., Marsal, J.R., Cascant, P., González-Alujas, T., Evangelista, A., Brotons, C., Moral, I., Permanyer-Miralda, G., García-Dorado, D., Tornos, P., Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area. Eur. J. Prev. Cardiol. 20 (2013), 1022–1030.
18. [18] Ngo, M.V., Gottdiener, J.S., Fletcher, R.D., Fernicola, D.J., Gersh, B.J., Smoking and obesity are associated with the progression of aortic stenosis. Am. J. Geriatr. Cardiol. 10 (2001), 86–90.
19. [19] Ouchi, N., Walsh, K., Adiponectin as an anti-inflammatory factor. Clin. Chim. Acta 380 (2007), 24–30.
20. [20] Abbasi, F., Farin, H.M., Lamendola, C., McLaughlin, T., Schwartz, E.A., Reaven, G.M., Reaven, P.D., The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. J. Clin. Endocrinol. Metab. 91 (2006), 5002–5007.
21. [21] Iwashima, Y., Katsuya, T., Ishikawa, K., Kida, I., Ohishi, M., Horio, T., Ouchi, N., Ohashi, K., Kihara, S., Funahashi, T., Rakugi, H., Ogihara, T., Association of hypoadiponectinemia with smoking habit in men. Hypertension 45 (2005), 1094–1100.
22. [22] Efstathiou, S.P., Skeva, I.I., Dimas, C., Panagiotou, A., Parisi, K., Tzanoumis, L., Kafouri, A., Bakratsas, K., Mountokalakis, T.D., Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. Atherosclerosis 205 (2009), 632–636.
23. [23] Li, M., Li, C., Liu, Y., Chen, Y., Wu, X., Yu, D., Werth, V.P., Williams, K.J., Liu, M.L., Decreased secretion of adiponectin through its intracellular accumulation in adipose tissue during tobacco smoke exposure. Nutr. Metab. (Lond.), 12, 2015, 15.
24. [24] Makowski, L., Hotamisligil, G.S., Fatty acid binding proteins–the evolutionary crossroads of inflammatory and metabolic responses. J. Nutr. 134 (2004), 2464S–2468S.
25. [25] Farooqi, I.S., O'Rahilly, S., 20 years of leptin: human disorders of leptin action. J. Endocrinol. 223 (2014), T63–T70.
26. [26] Miller, M., Zhan, M., Havas, S., High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the third national health and nutrition examination survey. Arch. Intern. Med. 165 (2005), 2063–2068.
27. [27] Danesh, J., Collins, R., Appleby, P., Peto, R., Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998), 1477–1482.
28. [28] Xu, X.J., Apovian, C., Hess, D., Carmine, B., Saha, A., Ruderman, N., Improved insulin sensitivity 3 Months after RYGB surgery is associated with increased subcutaneous adipose tissue AMPK activity and decreased oxidative stress. Diabetes 64 (2015), 3155–3159.
29. [29] Kolehmainen, M., Ulven, S.M., Paananen, J., de Mello, V., Schwab, U., Carlberg, C., Myhrstad, M., Pihlajamäki, J., Dungner, E., Sjölin, E., Gunnarsdottir, I., Cloetens, L., Landin-Olsson, M., Akesson, B., Rosqvist, F., Hukkanen, J., Herzig, K.H., Dragsted, L.O., Savolainen, M.J., Brader, L., Hermansen, K., Risérus, U., Thorsdottir, I., Poutanen, K.S., Uusitupa, M., Arner, P., Dahlman, I., Healthy nordic diet downregulates the expression of genes involved in inflammation in subcutaneous adipose tissue in individuals with features of the metabolic syndrome. Am. J. Clin. Nutr. 101 (2015), 228–239.
30. [30] Hirata, Y., Tabata, M., Kurobe, H., Motoki, T., Akaike, M., Nishio, C., Higashida, M., Mikasa, H., Nakaya, Y., Takanashi, S., Igarashi, T., Kitagawa, T., Sata, M., Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J. Am. Coll. Cardiol. 58 (2011), 248–255.
31. [31] Cheng, K.H., Chu, C.S., Lee, K.T., Lin, T.H., Hsieh, C.C., Chiu, C.C., Voon, W.C., Sheu, S.H., Lai, W.T., Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int. J. Obes. (Lond.) 32 (2008), 268–274.
32. [32] Hajek, P., Etter, J.F., Benowitz, N., Eissenberg, T., McRobbie, H., Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 109 (2014), 1801–1810.